Literature DB >> 22101066

The crisis of no new antibiotics--what is the way forward?

Laura J V Piddock1.   

Abstract

Antibiotic use not only underpins modern medicine, but has brought huge changes to the world, especially in expectations of survival of children into adulthood. The theme of World Health Day, 2011, was "antimicrobial resistance: no action today and no cure tomorrow". The demise of antibacterial drug discovery brings the spectre of untreatable infections. To prevent this crisis immediate action is needed and a new initiative, Antibiotic Action, has been launched. By bringing together communities who need these drugs with academia, health-care professionals, and pharmaceutical companies, this initiative aims to strengthen and enhance academic-industrial partnerships, bring about revision of costly and laborious processes of licensing and regulation of new antibiotics, and address the economics of antimicrobial drugs (cost of use vs profit). A global alliance for antibiotic drug discovery and development would provide a platform for these initiatives.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101066     DOI: 10.1016/S1473-3099(11)70316-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  102 in total

Review 1.  Development of novel antibacterial drugs to combat multiple resistant organisms.

Authors:  Matteo Bassetti; Elda Righi
Journal:  Langenbecks Arch Surg       Date:  2015-02-11       Impact factor: 3.445

Review 2.  Investigational antimicrobial agents of 2013.

Authors:  Michael J Pucci; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

3.  The antibiotic resistance crisis: part 2: management strategies and new agents.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-05

4.  The antibiotic resistance crisis: part 1: causes and threats.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-04

5.  Ten tips on how to win the war against resistance to antibiotics.

Authors:  Jean Carlet
Journal:  Intensive Care Med       Date:  2015-01-09       Impact factor: 17.440

6.  The political and ethical challenge of multi-drug resistant tuberculosis.

Authors:  Chris Degeling; Christopher Mayes; Wendy Lipworth; Ian Kerridge; Ross Upshur
Journal:  J Bioeth Inq       Date:  2015-01-29       Impact factor: 1.352

7.  Comparison of antibacterial effects between antimicrobial peptide and bacteriocins isolated from Lactobacillus plantarum on three common pathogenic bacteria.

Authors:  Liu Ming; Qian Zhang; Le Yang; Jian-An Huang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 8.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 9.  Crisis in Infectious Diseases: 2 Decades Later.

Authors:  Arturo Casadevall
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079

Review 10.  How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.